These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24757225)

  • 1. Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices.
    Kudva YC; Carter RE; Cobelli C; Basu R; Basu A
    Diabetes Care; 2014; 37(5):1184-90. PubMed ID: 24757225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closed-loop artificial pancreas systems: engineering the algorithms.
    Doyle FJ; Huyett LM; Lee JB; Zisser HC; Dassau E
    Diabetes Care; 2014; 37(5):1191-7. PubMed ID: 24757226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated Insulin Delivery: The Artificial Pancreas Technical Challenges.
    Hernando ME; García-Sáez G; Gómez EJ; Pérez-Gandía C; Rodríguez-Herrero A
    Am J Ther; 2020; 27(1):e62-e70. PubMed ID: 31567196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
    Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
    Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.
    Ward WK; Castle JR; El Youssef J
    J Diabetes Sci Technol; 2011 Nov; 5(6):1373-80. PubMed ID: 22226254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.
    Gingras V; Taleb N; Roy-Fleming A; Legault L; Rabasa-Lhoret R
    Diabetes Obes Metab; 2018 Feb; 20(2):245-256. PubMed ID: 28675686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed-loop artificial pancreas: current studies and promise for the future.
    Weinzimer SA
    Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):88-92. PubMed ID: 22327368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The First Hybrid Closed-Loop Insulin Pump: Will It Meet Its Potential?
    Hirsch IB
    Diabetes Technol Ther; 2017 Mar; 19(3):140-141. PubMed ID: 28287847
    [No Abstract]   [Full Text] [Related]  

  • 11. The closed-loop artificial pancreas in 2020.
    Fabris C; Kovatchev B
    Artif Organs; 2020 Jul; 44(7):671-679. PubMed ID: 32384582
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes.
    Ruan Y; Bally L; Thabit H; Leelarathna L; Hartnell S; Tauschmann M; Wilinska ME; Evans ML; Mader JK; Kojzar H; Dellweg S; Benesch C; Arnolds S; Pieber TR; Hovorka R
    Diabetes Obes Metab; 2018 Aug; 20(8):2004-2008. PubMed ID: 29577536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in development of an artificial pancreas.
    Klonoff DC; Cobelli C; Kovatchev B; Zisser HC
    J Diabetes Sci Technol; 2009 Sep; 3(5):1002-4. PubMed ID: 20144412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.
    Dadlani V; Pinsker JE; Dassau E; Kudva YC
    Curr Diab Rep; 2018 Aug; 18(10):88. PubMed ID: 30159816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodic-zone model predictive control for diurnal closed-loop operation of an artificial pancreas.
    Gondhalekar R; Dassau E; Zisser HC; Doyle FJ
    J Diabetes Sci Technol; 2013 Nov; 7(6):1446-60. PubMed ID: 24351171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.
    Weisman A; Bai JW; Cardinez M; Kramer CK; Perkins BA
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):501-512. PubMed ID: 28533136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.
    Cameron FM; Ly TT; Buckingham BA; Maahs DM; Forlenza GP; Levy CJ; Lam D; Clinton P; Messer LH; Westfall E; Levister C; Xie YY; Baysal N; Howsmon D; Patek SD; Bequette BW
    Diabetes Technol Ther; 2017 Sep; 19(9):527-532. PubMed ID: 28767276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas.
    Bequette BW
    Diabetes Technol Ther; 2005 Feb; 7(1):28-47. PubMed ID: 15738702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.